Skip to content

DYAX CORP

Delisted

CIK 907562fmd_1RRDFEJJSEAK925Q9F3V9V9Q91Services · Services-Commercial Physical & Biological ResearchTemplate: Standard

Coverage: Jan 02, 2009 to Sep 30, 2015, 23 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011FY2012FY2013FY2014
Total revenues225149555482
Cost of revenue–11235
Gross profit–5148525177
Research and development473235303036
Selling, general and administrative263438403940
Operating income(54)(14)(25)(19)(17)(1)
Interest expense101210101111
Interest and investment income221–––
Other non-operating income (expense)(8)(10)(10)(10)(11)(11)
Net income(62)(25)(35)(29)(28)(12)
DYAX CORP financial statements · FinancialMD